Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases

Author:

Chellappan Dinesh K.1,Yee Lim W.2,Xuan Kong Y.2,Kunalan Kishen2,Rou Lim C.2,Jean Leong S.2,Ying Lee Y.2,Wie Lee X.2,Chellian Jestin1,Mehta Meenu3,Satija Saurabh3,Singh Sachin K.3,Gulati Monica3,Dureja Harish4ORCID,Da Silva Mateus Webba5,Tambuwala Murtaza M.5ORCID,Gupta Gaurav6ORCID,Paudel Keshav R.78ORCID,Wadhwa Ridhima89,Hansbro Philip M.7810,Dua Kamal891011ORCID

Affiliation:

1. Department of Life Sciences, School of PharmacyInternational Medical University Kuala Lumpur Malaysia

2. School of PharmacyInternational Medical University Kuala Lumpur Malaysia

3. School of Pharmaceutical SciencesLovely Professional University Phagwara Punjab India

4. Department of Pharmaceutical SciencesMaharishi Dayanand University Rohtak Haryana India

5. School of Pharmacy and Pharmaceutical SciencesUlster University County Londonderry Northern Ireland United Kingdom

6. School of PhamacySuresh Gyan Vihar University Jaipur India

7. School of Life SciencesUniversity of Technology Sydney Sydney New South Wales Australia

8. Centre for InflammationCentenary Institute Sydney New South Wales Australia

9. Discipline of Pharmacy, Graduate School of HealthUniversity of Technology Sydney Ultimo New South Wales Australia

10. Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and PharmacyUniversity of Newcastle Callaghan New South Wales Australia

11. School of Pharmaceutical SciencesShoolini University Solan Himachal Pradesh India

Funder

National Health and Medical Research Council

University of Technology Sydney

Publisher

Wiley

Subject

Drug Discovery

Reference171 articles.

1. Neutrophils and acute lung injury

2. Airway inflammation in chronic obstructive pulmonary disease;Angelis N.;Journal of Thoracic Disease,2014

3. Asher M. I. &Ellwood P.(2014). The global asthma report 2014.

4. EPI-hNE4, a Proteolysis-Resistant Inhibitor of Human Neutrophil Elastase and Potential Anti-Inflammatory Drug for Treating Cystic Fibrosis

5. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3